cdmo.directory
← Compare landing

Ajinomoto Bio-Pharma Services vs LGC Biosearch Technologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/ajibio-pharma/biosearchtech

CategoryAjinomoto Bio-Pharma ServicesLGC Biosearch Technologies
Listed sitecdmocdmo
SummaryAjinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service.GMP-compliant manufacturer of custom oligos, qPCR probes, and diagnostic kits for infectious diseases, oncology, and prenatal testing; ISO 13485-certified for clinical and diagnostic markets.
Services
  • Process Development
  • Small Molecule Development & Manufacturing
  • Biologics Development & Manufacturing
  • Peptide Manufacturing
  • Oligonucleotide Manufacturing
  • ADC (Antibody-Drug Conjugate) Manufacturing
  • Quality Control Testing
  • CMC Analytical Development
  • CMC Analytical Development
  • Oligonucleotide Manufacturing
  • Quality Control Testing
Modalities
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Oligonucleotide
  • Gene Therapy
  • Peptide
  • Oligonucleotide
IndicationsData not yet provided.
  • Oncology
  • Infectious Disease
  • Rare Disease
Locations
  • Belgium, Belgium, Belgium
  • United States, United States
  • Japan, Japan
  • India, India
Data not yet provided.
CertificationsData not yet provided.
  • ISO · Identifier: ISO 9001:2015
  • ISO · Identifier: ISO 13485
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.